Targeting WEE1 to overcome ARID1A mutation-driven osimertinib resistance in EGFR-mutant lung cancer. Fukuda K, Nanjo S, Takeuchi S, Chakrabarti T, et al. J Thorac Oncol 2025 Jun 13:S1556-0864(25)00766.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fukuda K, Nanjo S, Takeuchi S, Chakrabarti T, et al. Targeting WEE1 to overcome ARID1A mutation-driven osimertinib resistance in EGFR-mutant lung cancer. J Thorac Oncol 2025 Jun 13:S1556-0864(25)00766.
PMID: 40518016